SACUVIA 50MG TAB

Sacuvia 50mg Tablet – ARNI Therapy for Chronic Heart Failure

Sacuvia 50mg is a prescription medicine containing Sacubitril 24mg and Valsartan 26mg, used in the management of chronic heart failure with reduced ejection fraction (HFrEF). This innovative combination belongs to the class of ARNI (Angiotensin Receptor-Neprilysin Inhibitors) and is clinically proven to reduce the risk of cardiovascular death and hospitalization in patients with heart failure.

Key Features:

• ✅ Contains Sacubitril 24mg + Valsartan 26mg

• ✅ Indicated for chronic heart failure (HFrEF)

• ✅ Reduces hospitalization and mortality risk

• ✅ Improves cardiac function and quality of life

• ✅ 50mg strength – often used as an initial or titrated dose

• ✅ Once or twice-daily dosing (as prescribed)

How Sacuvia Works:

• Sacubitril: Inhibits neprilysin, enhancing levels of natriuretic peptides that help reduce fluid overload and relax blood vessels

• Valsartan: Blocks angiotensin II receptors, lowering blood pressure and preventing heart remodeling
  Together, they offer superior protection compared to traditional ACE inhibitors or ARBs alone.

Directions for Use:

Take as directed by your physician, usually twice daily. Can be taken with or without food. Do not stop medication without medical advice.

Important Notes:

• Prescription-only medication

• Not for use during pregnancy or with ACE inhibitors

• Monitor blood pressure, potassium levels, and renal function regularly

• May cause dizziness, especially when starting treatment